vs

Side-by-side financial comparison of Albemarle Corporation (ALB) and Ardent Health, Inc. (ARDT). Click either name above to swap in a different company.

Ardent Health, Inc. is the larger business by last-quarter revenue ($1.6B vs $1.4B, roughly 1.1× Albemarle Corporation). Ardent Health, Inc. runs the higher net margin — 2.8% vs -29.0%, a 31.8% gap on every dollar of revenue.

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers...

Goodlife Health Clubs is a chain of health clubs, with more than 80 locations in Australia.

ALB vs ARDT — Head-to-Head

Bigger by revenue
ARDT
ARDT
1.1× larger
ARDT
$1.6B
$1.4B
ALB
Higher net margin
ARDT
ARDT
31.8% more per $
ARDT
2.8%
-29.0%
ALB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALB
ALB
ARDT
ARDT
Revenue
$1.4B
$1.6B
Net Profit
$-414.2M
$45.0M
Gross Margin
13.9%
Operating Margin
-15.2%
5.8%
Net Margin
-29.0%
2.8%
Revenue YoY
15.9%
Net Profit YoY
-650.1%
EPS (diluted)
$-3.88
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALB
ALB
ARDT
ARDT
Q4 25
$1.4B
$1.6B
Q3 25
$1.3B
$1.6B
Q2 25
$1.3B
$1.6B
Q1 25
$1.1B
$1.5B
Q4 24
$1.2B
Q3 24
$1.4B
$1.4B
Q2 24
$1.4B
$1.5B
Q1 24
$1.4B
Net Profit
ALB
ALB
ARDT
ARDT
Q4 25
$-414.2M
$45.0M
Q3 25
$-160.7M
$-23.5M
Q2 25
$22.9M
$73.0M
Q1 25
$41.3M
$41.4M
Q4 24
$75.3M
Q3 24
$-1.1B
$26.3M
Q2 24
$-188.2M
$42.8M
Q1 24
$2.4M
Gross Margin
ALB
ALB
ARDT
ARDT
Q4 25
13.9%
Q3 25
9.0%
Q2 25
14.8%
Q1 25
14.5%
Q4 24
11.2%
Q3 24
-7.7%
Q2 24
-0.7%
Q1 24
2.9%
Operating Margin
ALB
ALB
ARDT
ARDT
Q4 25
-15.2%
5.8%
Q3 25
-16.6%
-0.1%
Q2 25
3.6%
7.4%
Q1 25
1.8%
5.0%
Q4 24
0.4%
Q3 24
-81.9%
3.9%
Q2 24
-34.4%
5.6%
Q1 24
-13.2%
Net Margin
ALB
ALB
ARDT
ARDT
Q4 25
-29.0%
2.8%
Q3 25
-12.3%
-1.5%
Q2 25
1.7%
4.4%
Q1 25
3.8%
2.8%
Q4 24
6.1%
Q3 24
-78.9%
1.8%
Q2 24
-13.2%
2.9%
Q1 24
0.2%
EPS (diluted)
ALB
ALB
ARDT
ARDT
Q4 25
$-3.88
$0.32
Q3 25
$-1.72
$-0.17
Q2 25
$-0.16
$0.52
Q1 25
$0.00
$0.29
Q4 24
$0.29
Q3 24
$-9.45
$0.19
Q2 24
$-1.96
$0.34
Q1 24
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALB
ALB
ARDT
ARDT
Cash + ST InvestmentsLiquidity on hand
$709.6M
Total DebtLower is stronger
$3.2B
$1.1B
Stockholders' EquityBook value
$9.5B
$1.3B
Total Assets
$16.4B
$5.3B
Debt / EquityLower = less leverage
0.33×
0.84×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALB
ALB
ARDT
ARDT
Q4 25
$709.6M
Q3 25
$1.9B
$609.4M
Q2 25
$1.8B
$540.6M
Q1 25
$1.5B
$495.0M
Q4 24
$1.2B
Q3 24
$1.7B
$563.1M
Q2 24
$1.8B
$334.5M
Q1 24
$2.1B
Total Debt
ALB
ALB
ARDT
ARDT
Q4 25
$3.2B
$1.1B
Q3 25
$3.6B
$1.1B
Q2 25
$3.6B
$1.1B
Q1 25
$3.5B
$1.1B
Q4 24
$3.5B
Q3 24
$3.6B
$1.1B
Q2 24
$3.5B
$1.1B
Q1 24
$3.5B
Stockholders' Equity
ALB
ALB
ARDT
ARDT
Q4 25
$9.5B
$1.3B
Q3 25
$10.0B
$1.2B
Q2 25
$10.2B
$1.3B
Q1 25
$10.0B
$1.2B
Q4 24
$10.0B
Q3 24
$10.2B
$1.0B
Q2 24
$11.2B
$739.9M
Q1 24
$11.5B
Total Assets
ALB
ALB
ARDT
ARDT
Q4 25
$16.4B
$5.3B
Q3 25
$17.1B
$5.2B
Q2 25
$17.3B
$5.0B
Q1 25
$17.0B
$4.9B
Q4 24
$16.6B
Q3 24
$17.5B
$4.8B
Q2 24
$18.4B
$4.6B
Q1 24
$19.0B
Debt / Equity
ALB
ALB
ARDT
ARDT
Q4 25
0.33×
0.84×
Q3 25
0.36×
0.88×
Q2 25
0.35×
0.87×
Q1 25
0.35×
0.93×
Q4 24
0.35×
Q3 24
0.35×
1.08×
Q2 24
0.31×
1.46×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALB
ALB
ARDT
ARDT
Operating Cash FlowLast quarter
$388.5M
$223.4M
Free Cash FlowOCF − Capex
$233.1M
FCF MarginFCF / Revenue
16.3%
Capex IntensityCapex / Revenue
10.9%
Cash ConversionOCF / Net Profit
4.97×
TTM Free Cash FlowTrailing 4 quarters
$692.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALB
ALB
ARDT
ARDT
Q4 25
$388.5M
$223.4M
Q3 25
$355.6M
$154.4M
Q2 25
$-7.2M
$117.5M
Q1 25
$545.4M
$-24.8M
Q4 24
$674.0K
Q3 24
$240.5M
$89.7M
Q2 24
$362.9M
Q1 24
$98.0M
Free Cash Flow
ALB
ALB
ARDT
ARDT
Q4 25
$233.1M
Q3 25
$223.4M
Q2 25
$-126.8M
Q1 25
$362.8M
Q4 24
$-355.1M
Q3 24
$-62.6M
Q2 24
$-84.7M
Q1 24
$-481.4M
FCF Margin
ALB
ALB
ARDT
ARDT
Q4 25
16.3%
Q3 25
17.1%
Q2 25
-9.5%
Q1 25
33.7%
Q4 24
-28.8%
Q3 24
-4.6%
Q2 24
-5.9%
Q1 24
-35.4%
Capex Intensity
ALB
ALB
ARDT
ARDT
Q4 25
10.9%
Q3 25
10.1%
Q2 25
9.0%
Q1 25
17.0%
Q4 24
28.9%
Q3 24
22.4%
Q2 24
31.3%
Q1 24
42.6%
Cash Conversion
ALB
ALB
ARDT
ARDT
Q4 25
4.97×
Q3 25
Q2 25
-0.31×
1.61×
Q1 25
13.19×
-0.60×
Q4 24
0.01×
Q3 24
3.41×
Q2 24
Q1 24
40.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALB
ALB

Energy Storage$759.1M53%
Specialties$348.9M24%
Ketjen$320.1M22%

ARDT
ARDT

Segment breakdown not available.

Related Comparisons